Javascript must be enabled to continue!
Volume of Aneurysmal Subarachnoid Hematoma Measured Quantitatively by 3D Slicer to Predict Symptomatic Cerebral Vasospasm
View through CrossRef
Background and Objectives:
Aneurysmal subarachnoid hemorrhage is strongly associated with symptomatic cerebral vasospasm. This study aims to investigate whether a quantitative measure of aneurysmal subarachnoid hematoma by 3D Slicer is more valuable for vasospasm risk prediction compared with modified Fisher scale and the new scale by Eagles.
Materials and Methods:
We performed a retrospective research of Digital Imaging and Communications in Medicine format (DICOM) in aneurysmal patients treated at our institution from 2019 to 2020. Association between vasospasm and hematoma volume by 3D Slicer was explored by univariate and multivariate analyses. Value of risk prediction was compared through area under the receiver operator characteristic curve (AUC) among the modified Fisher scale, the new scale by Eagles, and hematoma volume by 3D Slicer.
Results:
Hematoma volume by 3D Slicer had a significant relationship with vasospasm both by one-way analysis of variance (ANOVA;
F
= 19.37,
P
< 0.001) and a binary logistic regression analysis (odds ratio [OR] = 1.05,
P
= 0.016). Hematoma volume by 3D Slicer had a significantly higher AUC (0.708; 95% confidence interval [CI]: 0.618–0.798,
P
< 0.001) than the modified Fisher scale and the new scale by Eagles. The optimal diagnostic threshold for hematoma volume by 3D Slicer was 15.98 ml, and the sensitivity and specificity were 73.5% and 58.6%, respectively.
Conclusions:
Volume of aneurysmal subarachnoid hematoma measured quantitatively by 3D Slicer can improve the predictive value for symptomatic cerebral vasospasm.
Ovid Technologies (Wolters Kluwer Health)
Title: Volume of Aneurysmal Subarachnoid Hematoma Measured Quantitatively by 3D Slicer to Predict Symptomatic Cerebral Vasospasm
Description:
Background and Objectives:
Aneurysmal subarachnoid hemorrhage is strongly associated with symptomatic cerebral vasospasm.
This study aims to investigate whether a quantitative measure of aneurysmal subarachnoid hematoma by 3D Slicer is more valuable for vasospasm risk prediction compared with modified Fisher scale and the new scale by Eagles.
Materials and Methods:
We performed a retrospective research of Digital Imaging and Communications in Medicine format (DICOM) in aneurysmal patients treated at our institution from 2019 to 2020.
Association between vasospasm and hematoma volume by 3D Slicer was explored by univariate and multivariate analyses.
Value of risk prediction was compared through area under the receiver operator characteristic curve (AUC) among the modified Fisher scale, the new scale by Eagles, and hematoma volume by 3D Slicer.
Results:
Hematoma volume by 3D Slicer had a significant relationship with vasospasm both by one-way analysis of variance (ANOVA;
F
= 19.
37,
P
< 0.
001) and a binary logistic regression analysis (odds ratio [OR] = 1.
05,
P
= 0.
016).
Hematoma volume by 3D Slicer had a significantly higher AUC (0.
708; 95% confidence interval [CI]: 0.
618–0.
798,
P
< 0.
001) than the modified Fisher scale and the new scale by Eagles.
The optimal diagnostic threshold for hematoma volume by 3D Slicer was 15.
98 ml, and the sensitivity and specificity were 73.
5% and 58.
6%, respectively.
Conclusions:
Volume of aneurysmal subarachnoid hematoma measured quantitatively by 3D Slicer can improve the predictive value for symptomatic cerebral vasospasm.
Related Results
Blood free Radicals Concentration Determined by Electron Paramagnetic Resonance Spectroscopy and Delayed Cerebral Ischemia Occurrence in Patients with Aneurysmal Subarachnoid Hemorrhage
Blood free Radicals Concentration Determined by Electron Paramagnetic Resonance Spectroscopy and Delayed Cerebral Ischemia Occurrence in Patients with Aneurysmal Subarachnoid Hemorrhage
Abstract
Pathophysiology of delayed cerebral ischemia and cerebral vasospasm following aneurysmal subarachnoid hemorrhage is still poorly recognized, however free rad...
Combination Therapy with Clazosentan and Fasudil Hydrochloride Under Strict Fluid Management Is Associated with Reduced Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage
Combination Therapy with Clazosentan and Fasudil Hydrochloride Under Strict Fluid Management Is Associated with Reduced Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage
Abstract
Objective
Cerebral vasospasm following aneurysmal subarachnoid hemorrhage (aSAH) is a major cause of delayed cerebral ischemia (DCI) and poor functional o...
Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia
Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia
OBJECTIVE
Intravenous (IV) milrinone is a promising option for the treatment of cerebral vasospasm with delayed cerebral ischemia (DCI) after aneurysmal subarac...
Vasospasm in Cerebral Inflammation
Vasospasm in Cerebral Inflammation
All forms of cerebral inflammation as found in bacterial meningitis, cerebral malaria, brain injury, and subarachnoid haemorrhage have been associated with vasospasm of cerebral ar...
Haemodynamic and anaesthetic management of patients undergoing endovascular therapy for cerebral vasospasm
Haemodynamic and anaesthetic management of patients undergoing endovascular therapy for cerebral vasospasm
Abstract
Background: Cerebral vasospasm is a common and devastating complication after a subarachnoid haemorrhage (SAH). Current guidelines for treatment recommend hypert...
Determinants of Cerebrovascular Reserve in Patients with Significant Carotid Stenosis
Determinants of Cerebrovascular Reserve in Patients with Significant Carotid Stenosis
Abstract
Introduction
In patients with 70% to 99% diameter carotid artery stenosis cerebral blood flow reserve may be protectiv...
Real-world data of clazosentan for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study
Real-world data of clazosentan for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study
Abstract
Aneurysmal subarachnoid hemorrhage (aSAH) may lead to cerebral vasospasm which is significantly associated with morbidity and mortality. Clazosentan, an endothelin...
Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage
Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage
Object. Vasospasm remains a significant source of neurological morbidity and mortality following aneurysmal subarachnoid hemorrhage (SAH), despite advances in current medical, surg...

